Website & contact details
- Website
Ottimo Pharma Limited
- Incorporated
- 3 March 2017 (9 years)
- Previously known as
- Ultrahuman Eight Limited (until 23 September 2024)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Srinivas Akkaraju
- Accounts type
- Group
- Region
- South East
- Address
- C/o Kreston Reeves LLP Innovation HouseRamsgate RoadSandwichCT13 9FF
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 4 February 2027
- Last conf. stmt
- 21 January 2026
Officers 7 active
Officer details are public data from the Companies House register.
American
Born April 1956 (70)
Akkaraju, Srinivas
Director · Appointed 18 December 2024
American
Born March 1968 (58)
Director · Appointed 18 December 2024
American
Born January 1982 (44)
Thompson, Peter Armstrong
Director · Appointed 18 December 2024
American
Born July 1959 (67)
Sabry, James Henderson
Director · Appointed 15 October 2024
American
Born December 1958 (67)
Epstein, David Robert
Director · Appointed 7 October 2024
American
Born July 1961 (65)
Italian
Born January 1970 (56)
Officer history (5 former)
17 March 2025
18 December 2024
Appointed Akkaraju, Srinivas as Director
18 December 2024
18 December 2024
Appointed Thompson, Peter Armstrong as Director
18 December 2024
15 October 2024
Appointed Sabry, James Henderson as Director
7 October 2024
Appointed Epstein, David Robert as Director
28 September 2024
9 February 2022
13 November 2020
Resigned Edwards, Jon as Director
13 November 2020
28 July 2017
6 April 2017
6 April 2017
Appointed Edwards, Jon as Director
3 March 2017
3 March 2017
3 March 2017
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (2)
6 April 2017
6 April 2017
Financials
Balance sheet as at 31 December 2025 · group accounts
- Net Assets
- £84,556,182
- Cash
- £82,356,857
- Profit
- (£35,346,914)
- Employees
- 9
- Debt Ratio
- 10%
- Current Ratio
- 9.2x
- Return on Equity
- -42%
Trend
Net Assets
Balance sheet detail
| 2025 | 2023 | 2020 | 2019 | |
|---|---|---|---|---|
| Fixed Assets | £5,288,666 | |||
| Current Assets | £88,984,373 | £1,160,444 | £4,451,536 | £81,952 |
| Cash | £82,356,857 | £984,841 | £4,313,392 | £67,108 |
| Creditors (< 1 year) | £9,716,857 | £180,392 | £122,652 | £4,920 |
| Net Current Assets | £79,267,516 | £980,052 | £4,328,884 | £77,032 |
| Net Assets | £84,556,182 | £980,052 | £4,328,884 | £77,032 |
| Shareholder Funds | £84,556,182 | £980,052 | £4,328,884 | £77,032 |
Filings 74
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 8 May 2026 | Group of companies' accounts | 31 December 2025 | ||
| 23 March 2026 | Confirmation statement with updates | 21 January 2026 | ||
| 20 March 2026 | Replacement filing for the appointment of a director | |||
| 26 February 2026 | Director's details changed | |||
| 26 February 2026 | Director's details changed |
Some other companies at this address
Other companies in this industry
Newcastle Upon Tyne
Edinburgh
Edinburgh
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →